Bax Inhibitor-1 down-regulation in the progression of chronic liver diseases

by Burra Patrizia, Cardin Romilda, Farinati Fabio, Kotsafti Andromachi, Bortolami Marina
Published 2010-04-01

Autophagy and apoptosis-related genes in chronic liver disease and hepatocellular carcinoma

by Kotsafti Andromachi, Farinati Fabio, Cardin Romilda, Cillo Umberto, Nitti Donato, Bortolami Marina
Published 2012-08-01

Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorect...

by De Paoli Massimo, Hritz István, Molnár László D, István Gábor, Cardin Romilda, Farinati Fabio, Herszényi László, Plebani Mario, Tulassay Zsolt
Published 2008-07-01

<it>Nidogen 1 </it>and <it>2 </it>gene promoters are aberrantly methylated in human gastrointestinal cancer

by Sasaki Takako, Farinati Fabio, Manfredini Stefano, Angusti Angela, Gafà Roberta, Veronese Angelo, Miotto Elena, Sabbioni Silvia, Ulazzi Linda, Lanza Giovanni, Negrini Massimo
Published 2007-02-01

Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study

by Zoli Marco, Rapaccini Gianludovico, Benvegnu Luisa, Del Poggio Paolo, Di Nolfo Maria, Giacomin Anna, Baldan Anna, Sergio Adriana, Farinati Fabio, Borzio Franco, Giannini Edoardo G, Caturelli Eugenio, Trevisani Franco
Published 2009-01-01